Pharma & Healthcare Headlines
Pfizer Secures 3-Year Tariff Relief
Pfizer Inc. has received a three-year reprieve from the US pharmaceutical import tariffs imposed by former President Donald Trump. The 100% tariff is set to take effect from October 1, but Pfizer will remain exempt for the next three years.
Zydus Lifesciences Extends Sterling Biotech Deal
Zydus Lifesciences and Sterling Biotech have agreed to extend the closing date for the acquisition of Sterling’s API business until December 31, 2025.
Lupin Gains US FDA Approval
Lupin has received FDA approval for its Abbreviated New Drug Application (ANDA) for Rivaroxaban Oral Suspension, used in treating venous thromboembolism.
IT & Software Updates
Newgen Software Faces Adverse Court Verdict
The Qatar Investment & Trade Court has ordered Newgen Software to pay Rs 12.65 crore ($1.37 million and 200,000 QAR) plus court costs for alleged project deficiencies and delays.
Infrastructure & Construction
AGI Infra Secures Rs 325 Crore Order
AGI Infra’s subsidiary has won a construction project valued at Rs 325 crore.
KNR Constructions Receives Rs 72.8 Crore Order
The company received a letter of acceptance from the Greater Hyderabad Municipal Corporation for a new construction project.
Atlantaa & Ircon Partner for Rs 2,485 Crore Expressway
Atlantaa signed an agreement with Ircon International for the Bhandara–Gadchiroli Expressway Project in Maharashtra.
Swan Defence Partners with Samsung Heavy Industries
Swan Defence enters a strategic pact for shipbuilding and maritime projects.
Pricol and BOE Varitronix Collaborate
Pricol partners with BOE Varitronix to localize optical bonding of vehicle displays.
Energy & Power Sector Updates
SJVN Commissions 128.88 MW of Bikaner Solar Project
SJVN’s arm achieved commercial operation of 128.88 MW capacity, bringing total commissioned capacity to 629.90 MW.
NHPC Revises Karnisar Solar Project Timeline
The remaining 85.72 MW of the 300 MW Karnisar Solar Power Project in Rajasthan is now expected to be commissioned by October 31, 2025.
KP Energy Signs MoU with Jeonbuk Province
Through KPI Green Hydrogen & Ammonia, KP Energy will collaborate with South Korea’s Jeonbuk Province for technology exchange and joint green hydrogen projects.
Waaree Energies Opens 950 MW Solar Module Facility
The Gujarat-based company has established a large-scale solar module manufacturing line.
PFC & REC Expand Transmission Arms
PFC has incorporated South Kalamb Power Transmission, while REC added Kempegowda Power Transmission and Barmer HYDC Power Transmission.
Oil India & GAIL Collaborate on Natural Gas
The two firms signed a pact to enhance cooperation across the natural gas value chain in India.
Financial & Banking Updates
Utkarsh SFB Sells Rs 24 Crore NPA to ARC
The bank approved the sale of Rs 24 crore in non-performing assets to an ARC for a consideration of Rs 11.40 crore.
Indian Bank Cuts Lending Rates
The bank reduced its Overnight MCLR by 10 bps to 7.95% and the 1-Month MCLR by 5 bps to 8.25%.
HUDCO Disburses Rs 25,839 Crore in H1 FY26
Loan sanctions stood at Rs 92,710 crore, with Q2 disbursements growing 43.6% YoY to Rs 13,026 crore.
CMS Info Systems Plans Workforce Reduction
The company will reduce headcount by 10% and has converted a Rs 100 crore one-time revenue opportunity into Rs 225 crore long-term recurring revenue.
Retail & Consumer Updates
Cantabil Retail Expands Nationwide
The company opened 11 new stores in September 2025, raising its total store count to 632.
Avenue Supermarts Opens New Store in Ghaziabad
The total number of stores now stands at 432.
Allied Blenders Commissions PET Bottle Unit
The Telangana facility, part of a Rs 525 crore backward integration program, will produce over 600 million bottles annually, improving gross margins by 300 bps by FY28.
Corporate & Strategic Developments
Ola Electric Raises Rs 877.6 Crore via OCRPS
The private placement will be issued from one arm to another, strengthening capital structure.
Tata Motors Expands Internationally
The company incorporated TML CV Holdings BV in the Netherlands and invested Rs 120 crore via Series C preference shares.
Prism Johnson Invests Rs 38.25 Crore in Insurance Subsidiary
The investment was made by subscribing to 2.39 crore equity shares on a rights basis.
Subex Extends APAC Partnership
Subex has secured a five-year extension in revenue assurance and fraud management with a leading APAC communications provider, valued at Rs 49.74 crore.
Sastasundar Ventures Approves Buyback
The unlisted subsidiary will repurchase up to 20.27 lakh shares at Rs 493.21 per share, totaling Rs 100 crore.
Phoenix Mills Subsidiaries Voluntarily Struck Off
Three non-material subsidiaries are no longer part of the group.
Man Industries Faces SEBI Penalties
Penalties imposed for non-consolidation of financials with Merino Shelters (FY2015-2021); core operations remain unaffected.
Reliance Infra Clarifies ED Survey
The FEMA investigation relates to a domestic EPC contract from 2010; no foreign exchange involved, with operations unaffected.
Power Grid Declared Successful Bidder
Selected under Tariff-Based Competitive Bidding (TBCB) for an Inter-State Transmission System (ISTS) project.
APL Apollo Upgraded by CRISIL
Long-term rating revised to ‘AA+’ with a stable outlook.
Nestle India Signs MoU with Food Processing Ministry
Plans to expedite greenfield and brownfield investments in Odisha and existing sites over the next 2–3 years.
Summary
This month’s corporate and stock updates highlight major developments across pharmaceuticals, IT, infrastructure, energy, banking, and retail sectors. Key takeaways include Pfizer’s tariff relief, significant solar and transmission expansions, strategic MoUs with international partners, new product approvals, and strong corporate expansions and investments by leading Indian firms. Investors should watch these developments as they shape sectoral growth and market sentiment.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.